Lobbying client · LD-2 disclosures
Vivex Biologics
Florida
14 filings from 2 registrants · 2024–2026 · latest filed Jul 20, 2026
Reported on its behalf
$950K
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$950K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
14 filings
$950K on those filings
Medicare/Medicaid
MMM
8 filings
$400K on those filings
Science/Technology
SCI
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
Who did the lobbying
Every lobbyist named on this client's filings.
- John Mcmanus The Mcmanus Group11 filingsthrough 2026
- Alex Whalen The Mcmanus Group9 filingsthrough 2026
- Timothy Costa Continental Strategy, LLCCovered position: Former Chief of Staff to Dan Meuser5 filingsthrough 2026
- Luke Nickless Continental Strategy, LLCCovered position: Former Senior Policy Advisor, Appropriations, House Committee on the Budget2 filingsthrough 2026
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: vivex-biologics.